Findings in humanized-mouse model suggest benefit of further studies in HIV pre-exposure prophylaxis.
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000818:Animals; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004195:Disease Models, Animal; D004338:Drug Combinations; D000068679:Emtricitabine; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D006678:HIV / Q000276:immunology* / Q000472:pathogenicity; D015483:HIV Antibodies / Q000097:blood; D015658:HIV Infections / Q000097:blood / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D017053:Infection Control; D016031:Liver Transplantation; D051379:Mice; D016273:Occupational Exposure / Q000009:adverse effects; D063065:Organophosphonates / Q000008:administration & dosage*; D009943:Organophosphorus Compounds; D000068698:Tenofovir; D013950:Thymus Gland / Q000637:transplantation; D018183:Transplantation Chimera
D019380:Anti-HIV Agents; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D015483:HIV Antibodies; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003841:Deoxycytidine; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine